BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer - Wikidata - awgldk - TriplyDB

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

http://www.wikidata.org/entity/Q28277666

about

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients Gene regulation in primates evolves under tissue-specific selection pressures Breast cancer susceptibility gene 1 (BRCA1) predict clinical outcome in platinum- and toxal-based chemotherapy in non-small-cell lung cancer (NSCLC) patients: a system review and meta-analysis A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma Human ASH1 expression in prostate cancer with neuroendocrine differentiation Adding pharmacogenomics to the development of new marine-derived anticancer agents BRCA1, a 'complex' protein involved in the maintenance of genomic stability Systemic and targeted therapies for early-stage lung cancer Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)Targeting DNA damage response in cancer therapy Sapacitabine for cancer Fine tuning chemotherapy to match BRCA1 status BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma.mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer Genome stability pathways in head and neck cancers Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study BRCA1: a novel prognostic factor in resected non-small-cell lung cancer A combination of genomic approaches reveals the role of FOXO1a in regulating an oxidative stress response pathway.ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.Feasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.Sex-specific and lineage-specific alternative splicing in primates.Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.BRCA1 and ERCC1 mRNA levels are associated with lymph node metastasis in Chinese patients with colorectal cancer.RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide Cellular responses of BRCA1-defective and triple-negative breast cancer cells and in vitro BRCA1 interactions induced by metallo-intercalator ruthenium(II) complexes containing chloro-substituted phenylazopyridine How close are we to customizing chemotherapy in early non-small cell lung cancer?BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection Are we ready to use biomarkers for staging, prognosis and treatment selection in early-stage non-small-cell lung cancer?The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells Enhancement of TGF-β signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer.

P2860

Q21144211-C286EDC6-1F1C-4F2B-BE17-CB7A8DFEC76E Q21145029-340559CF-E283-4FC9-BFE8-B5941E8D9F64 Q21198839-49A37A4F-4AEB-4724-BC27-7B6D4FC5C005 Q21558626-F1715B06-5CC0-45EE-9650-27752A67C6BA Q24319673-1E65AB2F-7743-4101-AB85-D9E52581629F Q25254985-FEFD5FFD-CCE2-4D46-98FE-D69CFE134C15 Q26853262-AB530AE1-8BCC-4247-9478-47F0740F03C8 Q26865490-B28B844E-E0B3-4797-BF7F-17C6EEACF75F Q27009492-D2B80A84-2290-4551-8A7F-A0459D34D6D7 Q27023204-03449258-7AC2-4FEB-BFB5-9EDF267049AA Q27024675-56B23C4F-FBBF-40D4-B781-06C9C85FBA82 Q27694529-7AEC2579-F21B-4903-B0A6-666278F27138 Q27851697-9FC8D3A1-AF10-411D-AED7-5F42A71A6BFB Q28246258-78EFCFCB-1A75-47DB-917B-72F68DC68C4E Q28387891-47EC4F2E-EC72-4F1E-B897-785684FECB87 Q28391355-4ECEBBC9-9B43-4586-A213-ED16C1E66245 Q28396304-B6A1827A-3DEA-48D0-B3D9-137B133DC814 Q28539096-FBC9ACB7-1BD9-4691-92D0-55FE80CBD524 Q28539722-D360BA15-25F7-4AC6-85CC-492559749057 Q30417640-FED7D5F5-6EBB-4BE7-80CA-8811E32C3B2E Q33305206-60C11531-B3DC-42D1-9A48-9E130CE0F848 Q33321232-D4D3B732-FF3D-471E-91FD-D9D0D3FFBD33 Q33327609-A3D0FA73-4445-4696-85F4-D005A6E63672 Q33408830-A20E41E7-7FBD-4B6A-8159-FE84D9253776 Q33438894-BAE74012-B5D8-4A50-81BD-0AB9F22A85BC Q33538053-5A385639-360B-4526-AA66-AC977CDABA9C Q33618915-757FA67D-B15F-4130-96C5-0B3E372F8BB5 Q33627191-CEF1BF80-67D6-4B9C-A6C8-1570A56CC69A Q34543746-AA77D246-0C0E-4A02-9474-BA8E4D9E56B0 Q34550974-D92EAD7E-5E10-4391-B41F-D0DB2AD9CF10 Q34621524-F68D1ACD-D45E-4CBF-8AFC-550BC6590B42 Q34625373-63DEE928-E98E-41E8-B121-9F6A070D511C Q34657570-9286ECDC-7638-4388-B78E-8017FCC8CB5F Q34994818-ADBF4F65-3C3D-4141-985A-E4E966089F8F Q35089211-F1662E79-4BBD-480C-8824-036561C79D4F Q35146944-1704609D-A2D3-420B-99D3-299FA2BA22BE Q35177820-4760758C-693B-435B-933A-A99F4D3F9121 Q35200402-2F2AE7CA-3D0A-4194-B550-58590059E57B Q35218534-A1D66342-D5C2-43F8-A2C5-C089A5C99258 Q35360788-7194D2E7-08BF-40B3-8EE3-EACBCA3F941A

P2860

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

http://www.wikidata.org/entity/Q28277666

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@ast

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@en

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@nl

type

label

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@ast

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@en

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@nl

prefLabel

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@ast

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@en

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@nl

P1433

Q28277666-59A8D580-5B26-4D9A-9B2C-D0FEC0D22ECB

P1476

Q28277666-30F80FD9-B71E-42E3-AFFC-36D72435D3A2

P2093

Q28277666-14926C20-3A33-4F86-B365-B96AC590E2E1

Q28277666-41296A3B-30D9-46AF-9046-449508667ECE

Q28277666-62CF372D-485C-486F-B0B1-9C10A2AF5650

Q28277666-6A7DDC46-CAA2-4043-936B-65B78D921EB2

Q28277666-890AE405-6739-4AB6-B2E7-D7558D0098E2

Q28277666-9EB2A08A-AC8E-4636-BB28-79438F5C878D

Q28277666-CD81E75B-AD6E-48EC-BF23-FFB6E7B92C3C

Q28277666-DBC3771A-23AE-4CE4-B497-976910778134

Q28277666-E2AACA57-4B75-4E15-B29B-A6E572F072D5

P304

Q28277666-D28C62C3-B331-47FC-B4ED-991F17CB03FB

P31

Q28277666-86EF9247-DC60-449F-A125-F330F72A3A71

P3181

Q28277666-12B486BD-23D1-4D32-827D-9868814E665C

P356

Q28277666-360725BA-F12A-4B64-85A6-0AD8398B33B9

P407

Q28277666-45B084F0-537E-4C70-8717-301D547E8C4C

P433

Q28277666-9ADFA844-A673-486A-8A31-18517417ADA4

P478

Q28277666-FBB38C44-9807-4B94-97E0-D43B733D7A2C

P50

Q28277666-1A1F32AE-A59B-4F53-8EA7-7192B716D732

Q28277666-5D1CF654-29FA-45C8-B310-248AC1692861

P577

Q28277666-3E1C0402-A308-41E2-B982-B1FD0FF9BF7B

P5875

Q28277666-EF53A094-3899-4648-9D4C-8CE0756DBAB8

P698

Q28277666-82A8EEE2-015C-4A15-A63C-D51745EAE7FD

P3181

P356

P1433

Human Molecular Genetics

P1476

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

@en

P2093

Cristina Queralt

http://www.w3.org/2001/XMLSchema#string

Joaquim Majo

http://www.w3.org/2001/XMLSchema#string

John Souglakos

http://www.w3.org/2001/XMLSchema#string

Jose Javier Sanchez

http://www.w3.org/2001/XMLSchema#string

Jose Maestre

http://www.w3.org/2001/XMLSchema#string

Jose Miguel Sanchez

http://www.w3.org/2001/XMLSchema#string

Maria Sanchez Ronco

http://www.w3.org/2001/XMLSchema#string

Miquel Taron

http://www.w3.org/2001/XMLSchema#string

Pedro Mendez

http://www.w3.org/2001/XMLSchema#string

P304

2443-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

763083

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/HMG/DDH260

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Enriqueta Felip

P577

2004-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8393361

http://www.w3.org/2001/XMLSchema#string

P698

15317748

http://www.w3.org/2001/XMLSchema#string